Unknown

Dataset Information

0

?-Linolenic Acid-Valproic Acid Conjugates: Toward Single-Molecule Polypharmacology for Multiple Sclerosis.


ABSTRACT: Multiple sclerosis (MS) is a complex inflammatory, degenerative, and demyelinating disease of the central nervous system. Although treatments exist, MS cannot be cured by available drugs, which primarily target neuroinflammation. Thus, it is feasible that a well concerted polypharmacological approach able to act at multiple points within the intricate network of inflammation, neurodegeneration, and demyelination/remyelination pathways would succeed where other drugs have failed. Starting from reported beneficial effects of ?-linolenic acid (ALA) and valproic acid (VPA) in MS, and by applying a rational strategy, we developed a small set of codrugs obtained by conjugating VPA and ALA through proper linkers. A cellular profiling identified 1 as a polypharmacological tool able not only to modulate microglia polarization, but also to counteract neurodegeneration and demyelination and induce oligodendrocyte precursor cell differentiation, by acting on multiple biochemical and epigenetic pathways.

SUBMITTER: Rossi M 

PROVIDER: S-EPMC7734798 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

α-Linolenic Acid-Valproic Acid Conjugates: Toward Single-Molecule Polypharmacology for Multiple Sclerosis.

Rossi Michele M   Petralla Sabrina S   Protti Michele M   Baiula Monica M   Kobrlova Tereza T   Soukup Ondrej O   Spampinato Santi Mario SM   Mercolini Laura L   Monti Barbara B   Bolognesi Maria Laura ML  

ACS medicinal chemistry letters 20201027 12


Multiple sclerosis (MS) is a complex inflammatory, degenerative, and demyelinating disease of the central nervous system. Although treatments exist, MS cannot be cured by available drugs, which primarily target neuroinflammation. Thus, it is feasible that a well concerted polypharmacological approach able to act at multiple points within the intricate network of inflammation, neurodegeneration, and demyelination/remyelination pathways would succeed where other drugs have failed. Starting from re  ...[more]

Similar Datasets

| S-EPMC7923232 | biostudies-literature
| S-EPMC10179906 | biostudies-literature
| S-EPMC6997421 | biostudies-literature
| S-EPMC5579177 | biostudies-literature
| S-EPMC6646899 | biostudies-literature
| S-EPMC8764440 | biostudies-literature
| S-EPMC5612619 | biostudies-literature
| S-EPMC6541350 | biostudies-literature
| S-EPMC9105512 | biostudies-literature
2019-05-08 | E-MTAB-7368 | biostudies-arrayexpress